Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous and intermittent levamisole. A controlled trial.

J Scott, P A Dieppe, E C Huskisson

    Annals of the Rheumatic Diseases
    |June 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Four new anti-inflammatory drugs responses and variations.

    The Medical journal of Malaysia·2022
    Same author

    Catecholamine excretion and pain.

    British journal of clinical pharmacology·2012
    Same author

    Indomethacin or amylobarbitone sodium for sleep in rheumatoid arthritis, with some observations on the use of sequential analysis.

    British journal of clinical pharmacology·2012
    Same author

    Modern management of mild-to-moderate joint pain due to osteoarthritis: a holistic approach.

    The Journal of international medical research·2010
    Same author

    Glucosamine and chondroitin for osteoarthritis.

    The Journal of international medical research·2008
    Same author

    Nimesulide, a balanced drug for the treatment of osteoarthritis.

    Clinical and experimental rheumatology·2001

    Intermittent levamisole therapy is as effective as continuous therapy for rheumatoid arthritis. This dosing schedule also resulted in fewer side effects, offering a potentially improved treatment option.

    Area of Science:

    • Rheumatology
    • Immunology
    • Pharmacology

    Background:

    • Rheumatoid arthritis (RA) is a chronic autoimmune disease.
    • Levamisole is an immunomodulatory agent used in RA treatment.
    • Continuous dosing regimens are common, but side effects can occur.

    Purpose of the Study:

    • To compare the efficacy and safety of intermittent levamisole therapy versus continuous levamisole therapy in patients with rheumatoid arthritis.

    Main Methods:

    • A double-blind, comparative clinical trial was conducted.
    • Patients received either intermittent levamisole (150 mg daily for 3 days/week) or continuous levamisole (150 mg daily).
    • Efficacy and side effect profiles were assessed.

    Main Results:

    Related Experiment Videos

    • Intermittent levamisole therapy demonstrated comparable efficacy to continuous therapy in treating rheumatoid arthritis.
    • The intermittent regimen was associated with slightly fewer adverse side effects compared to the continuous regimen.

    Conclusions:

    • Intermittent levamisole therapy presents a viable and potentially safer alternative for rheumatoid arthritis management.
    • This dosing strategy may improve patient tolerability without compromising therapeutic benefits.